drugset
drugset / Trial / NCT05789576

A Study to Investigate Efficacy and Safety of VTAMA® (Tapinarof) Cream, 1% in Plaque Psoriasis in the Head and Neck Region

NCT05789576 ↗

Phase 4 Completed 31 enrolled Organon and Co
NaSingle-groupOpen-labelTreatment

Summary

This is an open-label, multi-center study to evaluate the efficacy and safety of VTAMA (tapinarof) cream, 1% in adults with plaque psoriasis occurring in the head and neck region

Timeline

Start
2023-03-13
Primary completion
2023-06-30
Completion
2023-07-19

Drugs

EvaluationDrugModalityDoseRoute
Subject Tapinarof Other / unclassified 1 % Topical

Indications

psoriasis